首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Current Oncology
ISSN：1198-0052

Current Oncology

CURR ONCOL
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：约1.0个月
新锐分区：医学3区
年发文量：585
影响因子：3.4
JCR分区：Q2

基本信息

《当代肿瘤学》是一本同行评审的、加拿大的、在国际上享有盛誉的杂志。《当代肿瘤学》是加拿大癌症治疗领域的多学科媒体，由卫生保健工作者报道和回顾癌症治疗的进展。我们鼓励来自癌症医学各个领域的投稿，包括放射肿瘤学、外科肿瘤学、内科肿瘤学、儿科肿瘤学、病理学、癌症康复和生存率。在期刊上发表的文章通常包含与临床肿瘤学实践直接相关的信息，并具有明确的应用于当前或未来癌症医学实践的潜力。
1198-0052SCIE/Scopus收录/DOAJ开放期刊
3.4
点击查看最新影响趋势>
3.4
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：ONCOLOGY
SCIE
Q2
118/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：ONCOLOGY
SCIE
Q3
174/328
42
585
点击查看年发文量趋势图>
3%较易约1.0个月平均 3000 元/页ONCOLOGY-
2.9%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
73.33%100%0.71%
CiteScore：4.90
SJR：1.113
SNIP：1.039
学科类别分区排名百分位
大类：Medicine
小类：Oncology
Q2
162 / 415

期刊高被引文献

Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma.
来源期刊：Current oncologyDOI：10.3747/co.26.4345
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
来源期刊：Current oncologyDOI：10.3747/co.26.4595
Adjuvant therapy for stages II and III colon cancer: risk stratification, treatment duration, and future directions.
来源期刊：Current oncologyDOI：10.3747/co.26.5605
Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada.
来源期刊：Current oncologyDOI：10.3747/co.26.4625
Feasibility of a modified Atkins diet in glioma patients during radiation and its effect on radiation sensitization.
来源期刊：Current oncologyDOI：10.3747/co.26.4889
Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada.
来源期刊：Current oncologyDOI：10.3747/co.26.4743
Framing of the opioid problem in cancer pain management in Canada.
来源期刊：Current oncologyDOI：10.3747/co.26.4517
Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma.
来源期刊：Current oncologyDOI：10.3747/co.26.5421
An integrated knowledge translation approach to develop a shared decision-making strategy for use by Inuit in cancer care: a qualitative study.
来源期刊：Current oncologyDOI：10.3747/co.26.4729
Personalizing post-treatment cancer care: a cross-sectional survey of the needs and preferences of well survivors of breast cancer.
来源期刊：Current oncologyDOI：10.3747/co.26.4131
A primer on the genetics of medullary thyroid cancer.
来源期刊：Current oncologyDOI：10.3747/co.26.5553
Area-level income disparities in colorectal screening in Canada: evidence to inform future surveillance.
来源期刊：Current oncologyDOI：10.3747/co.26.4279
Patient-reported outcomes in Alberta: rationale, scope, and design of a database initiative.
来源期刊：Current oncologyDOI：10.3747/co.26.4919
Employment outcomes for recent Canadian radiation oncology graduates.
来源期刊：Current oncologyDOI：10.3747/co.26.4925
Testing e-mail content to encourage physicians to access an audit and feedback tool: a factorial randomized experiment.
来源期刊：Current oncologyDOI：10.3747/co.26.4829
Implementation of a comprehensive smoking cessation program in cancer care.
来源期刊：Current oncologyDOI：10.3747/co.26.5201
Clinical practice guideline for image-guided multimode tumour ablation therapy in hepatic malignant tumours.
来源期刊：Current oncologyDOI：10.3747/co.26.5423
The economic impact of the transition from branded to generic oncology drugs.
来源期刊：Current oncologyDOI：10.3747/co.26.4395
Active treatment in low-risk prostate cancer: a population-based study.
来源期刊：Current oncologyDOI：10.3747/co.26.4953
Factors influencing the use by radiation therapists of cancer symptom guides: a mixed-methods study.
来源期刊：Current oncologyDOI：10.3747/co.25.4198
Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.
来源期刊：Current oncologyDOI：10.3747/co.26.4951
FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study.
来源期刊：Current oncologyDOI：10.3747/co.26.4903
Psychedelics for psychological and existential distress in palliative and cancer care.
来源期刊：Current oncologyDOI：10.3747/co.26.5009
A retrospective observational study to estimate the attrition of patients across lines of systemic treatment for metastatic colorectal cancer in Canada.
来源期刊：Current oncologyDOI：10.3747/co.26.4861
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
来源期刊：Current oncologyDOI：10.3747/co.26.5001
Inter- and intraprovincial inequities in public coverage of cancer drug programs across Canada: a plea for the establishment of a pan-Canadian pharmacare program.
来源期刊：Current oncologyDOI：10.3747/co.26.4867
Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.
来源期刊：Current oncologyDOI：10.3747/co.26.5297
Panitumumab-induced pulmonary toxicity.
来源期刊：Current oncologyDOI：10.3747/co.26.5399
U.S. prevalence of endocrine therapy-naïve locally advanced or metastatic breast cancer.
来源期刊：Current oncologyDOI：10.3747/co.26.4163
Pembrolizumab-induced obstructive bronchiolitis in a patient with stage IV non-small-cell lung cancer.
来源期刊：Current oncologyDOI：10.3747/co.26.4859
Are patient education materials about cancer screening more effective when co-created with patients? A qualitative interview study and randomized controlled trial.
来源期刊：Current oncologyDOI：10.3747/co.26.4621
Combining prostate cancer radiotherapy with therapies targeting the androgen receptor axis.
来源期刊：Current oncologyDOI：10.3747/co.26.5005
Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
来源期刊：Current oncologyDOI：10.3747/co.26.4311
Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia.
来源期刊：Current oncologyDOI：10.3747/co.26.4068
Brain cancer survival in Canada 1996-2008: effects of sociodemographic characteristics.
来源期刊：Current oncologyDOI：10.3747/co.26.4273
Renal cell carcinoma in the Canadian Indigenous population.
来源期刊：Current oncologyDOI：10.3747/co.26.4707
Lack of accountability in upholding authorship standards in prominent medical oncology clinical trials.
来源期刊：Current oncologyDOI：10.3747/co.26.4789
Breast cancer screening policy-good science should trump bad politics.
来源期刊：Current oncologyDOI：10.3747/co.27.5661
The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada.
来源期刊：Current oncologyDOI：10.3747/co.26.5281
Updates from the 2019 American Society of Clinical Oncology and European Hematology Association annual meetings: a Canadian perspective on high-risk cytogenetics in multiple myeloma.
来源期刊：Current oncologyDOI：10.3747/co.26.5565
Resource use in the last three months of life by lung cancer patients in southern Ontario.
来源期刊：Current oncologyDOI：10.3747/co.26.4967
Recurrence and mortality after breast-conserving surgery without radiation.
来源期刊：Current oncologyDOI：10.3747/co.26.5225
Preferences of Canadian patients and physicians for adjuvant treatments for melanoma.
来源期刊：Current oncologyDOI：10.3747/co.26.5085
Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018.
来源期刊：Current oncologyDOI：10.3747/co.26.5517
Why are we organizing another costing supplement in Current Oncology?
来源期刊：Current oncologyDOI：10.3747/co.26.4975
Erratum: Current and emerging biomarkers in metastatic colorectal cancer.
来源期刊：Current oncologyDOI：10.3747/co.26.6145
Does the frequency of routine follow-up after curative treatment for head-and-neck cancer affect survival?
来源期刊：Current oncologyDOI：10.3747/co.26.4949
Canadian Lung Cancer Conference 2019.
来源期刊：Current oncologyDOI：10.3747/co.26.5105
Measuring colposcopy quality in Canada: development of population-based indicators.
来源期刊：Current oncologyDOI：10.3747/co.26.4709
Surgical attitudes toward preoperative breast magnetic resonance imaging in women with early-stage breast cancer.
来源期刊：Current oncologyDOI：10.3747/co.26.4227

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
否
否